Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Medsafe has won praise for moving quickly to stop sales of a herbal remedy linked to Covid-19.

Muscular Dystrophy Association Celebrates FDA Approval of Skyclarys, First Ever Treatment for Friedreich's Ataxia from Reata Pharmaceuticals

False advertising over Covid-19 cures targeted by Commerce Commission

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Monica Tsacheff on LinkedIn: Pfizer Bets On Medical Cannabis With $6.7 Billion Acquisition

Another Malaria Cure Draws Notice in Coronavirus Outbreak, This Time in Africa - WSJ

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

COVID-19 Lockdown Exit Analysis

COVID-19: Tests for herb Artemisia begin – DW – 05/15/2020

Medsafe blocks sales of COVID-19 'treatment' Artemisia annua extract

False advertising over Covid-19 cures targeted by Commerce Commission

Prof. Evangelos Terpos Discusses Belantab Mafodotin + Rd EHA 2022

COVID-19 Lockdown Exit Analysis